These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9859824)

  • 41. [Prognostic significance of p53 expression in gastric carcinoma].
    Sanz Esponera J
    An R Acad Nac Med (Madr); 1994; 111(3):477-83; discussion 483-4. PubMed ID: 7818034
    [No Abstract]   [Full Text] [Related]  

  • 42. Prognostic value of DNA ploidy and proliferating cell nuclear antigen in gastric cancer.
    Hirose K; Iida A; Yamaguchi A; Onchi H; Awata H; Katayama K; Nakagawara G
    Oncology; 1998; 55(4):300-6. PubMed ID: 9663419
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Nuclear P53 immunoreactivity associated with poor prognosis of gastric cancer: preliminary report].
    Yonemura Y; Fushida S; Tsugawa K; Yamaguchi A; Miyazaki I; Shiku H; Urano T
    Nihon Geka Gakkai Zasshi; 1992 Jun; 93(6):662. PubMed ID: 1630444
    [No Abstract]   [Full Text] [Related]  

  • 44. Clinical significance of DNA ploidy and S-phase fraction and their relation to p53 protein, c-erbB-2 protein and HCG in operable muscle-invasive bladder cancer.
    Fosså SD; Berner AA; Jacobsen AB; Waehre H; Kvarstein B; Urnes T; Ogreid P; Johansen TE; Silde J; Nesland JM
    Br J Cancer; 1993 Sep; 68(3):572-8. PubMed ID: 8102536
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proliferation kinetics and prognosis in gastric cancer after resection.
    Sendler A; Gilbertz KP; Becker I; Mueller J; Berger U; Fink U; van Beuningen D; Siewert JR
    Eur J Cancer; 2001 Sep; 37(13):1635-41. PubMed ID: 11527689
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic significance of tumor-host interaction in clinical gastric cancer: relationship between DNA ploidy and dendritic cell infiltration.
    Kakeji Y; Maehara Y; Korenaga D; Tsujitani S; Haraguchi M; Watanabe A; Orita H; Sugimachi K
    J Surg Oncol; 1993 Apr; 52(4):207-12. PubMed ID: 8468980
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation between telomerase activity and DNA ploidy in gastric cancer.
    Okusa Y; Shinomiya N; Ichikura T; Mochizuki H
    Oncology; 1998; 55(3):258-64. PubMed ID: 9560059
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Role of protein p21, p27, and p53 in the prognosis of patients surgically treated for gastric cancer].
    Di Martino N; Izzo G; Cosenza A; Renzi A; Monaco L; Torelli F; Basciotti A; Brillantino A; La Mura F
    Suppl Tumori; 2005; 4(3):S204-5. PubMed ID: 16437989
    [No Abstract]   [Full Text] [Related]  

  • 49. Early gastric carcinoma; analysis of its growth patterns.
    Inokuchi K
    Trop Gastroenterol; 1984; 5(3):113-23. PubMed ID: 6528350
    [No Abstract]   [Full Text] [Related]  

  • 50. [Patients with gastric cancer: analysis of DNA ploidy patterns].
    de Aretxabala X; Roa I; Yonemura Y; Araya JC; Hirose N; Miwa K; Miyasaki I
    Rev Med Chil; 1988 Oct; 116(10):977-80. PubMed ID: 3267889
    [No Abstract]   [Full Text] [Related]  

  • 51. [Alteration in DNA ploidy in the gastric stump mucosa: preliminary report].
    Fukuzawa K; Noguchi Y; Nomura K; Makino T; Tsuburaya A; Imada T; Matsumoto A
    Nihon Geka Gakkai Zasshi; 1992 Mar; 93(3):336. PubMed ID: 1513317
    [No Abstract]   [Full Text] [Related]  

  • 52. Prognostic analysis of familial gastric cancer in Chinese population.
    Ye YW; Dong RZ; Zhou Y; Du CY; Wang CM; Fu H; Shi YQ
    J Surg Oncol; 2011 Jul; 104(1):76-82. PubMed ID: 21400534
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DNA ploidy and its clinical implications in gastric cancer.
    Baba H; Korenaga D; Kakeji Y; Haraguchi M; Okamura T; Maehara Y
    Surgery; 2002 Jan; 131(1 Suppl):S63-70. PubMed ID: 11821789
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mast cell density and the context of clinicopathological parameters and expression of p185, estrogen receptor, and proliferating cell nuclear antigen in gastric carcinoma.
    Jiang YA; Zhang YY; Luo HS; Xing SF
    World J Gastroenterol; 2002 Dec; 8(6):1005-8. PubMed ID: 12439914
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Flow cytometric and immunohistochemical correlations in high incidence human solid tumors.
    Danesi DT; Spanò M; Antonini F; Altavista P; Catalano P; Cordelli E; Pasqualetti P; Santacroce C; Toscano MG; Mecozzi A; Fabiano A
    Tumori; 1997; 83(3):689-97. PubMed ID: 9267490
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [In vitro BrdU labeling for clinical use--flow cytometric analysis of proliferative activity in gastric cancers: preliminary report].
    Ohyama S; Yonemura Y; Kamata T; Kosaka T; Miwa K; Miyazaki I
    Nihon Geka Gakkai Zasshi; 1989 Apr; 90(4):629. PubMed ID: 2761533
    [No Abstract]   [Full Text] [Related]  

  • 57. Flow cytometric analysis of the DNA content of gastric cancer.
    Ballantyne KC; James PD; Robins RA; Baldwin RW; Hardcastle JD
    Br J Cancer; 1987 Jul; 56(1):52-4. PubMed ID: 3620318
    [No Abstract]   [Full Text] [Related]  

  • 58. Significance of cell proliferation measurement in gastric cancer.
    Schipper DL; Wagenmans MJ; Peters WH; Wagener DJ
    Eur J Cancer; 1998 May; 34(6):781-90. PubMed ID: 9797687
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of human p53 minigene with different 175 structures on gastric cancer cells].
    Fan Y; Yu YN
    Zhonghua Bing Li Xue Za Zhi; 2008 Aug; 37(8):549-50. PubMed ID: 19094467
    [No Abstract]   [Full Text] [Related]  

  • 60. [Double-labelling immunofluorescence study by quantum dots for simultaneous detection of two different antigens in paraffin embedded tissues].
    Chen HL; Zhu XB; Li BY; Yu BP
    Zhonghua Bing Li Xue Za Zhi; 2009 Jun; 38(6):420-2. PubMed ID: 19781352
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.